Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
Open Access
- 3 April 2007
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 59
- https://doi.org/10.1186/1471-2407-7-59
Abstract
Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen.Keywords
This publication has 49 references indexed in Scilit:
- The Expanding Cosmos of Nuclear Receptor CoactivatorsPublished by Elsevier ,2006
- Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cellsLife Sciences, 2006
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancersThe International Journal of Biochemistry & Cell Biology, 2004
- Urokinase-Type Plasminogen Activator System in Breast CancerCancer Research, 2004
- Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone IndependenceMolecular and Cellular Biology, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κBBiochemical and Biophysical Research Communications, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Transcription factors and breast cancerEndocrine-Related Cancer, 1998